Transtema: Strong Growth Momentum and Healthy Margins - Redeye

Redeye retains its positive view on Transtema following a solid Q3 report, showing high organic and acquired growth and healthy margins. While demand is strong, cost inflation puts pressure on Transtema’s operations, but management seems confident its margin target can be maintained. We raise our forecasts slightly and leave our Base Case unchanged.

Länk till analysen i sin helhet: https://www.redeye.se/research/861714/transtema-strong-growth-momentum-and-healthy-margins?utm_source=finwire&utm_medium=RSS